Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.addbeh.2009.03.014 http://scihub22266oqcxt.onion/10.1016/j.addbeh.2009.03.014 19345510/?report=reader!2729436!19345510     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 267.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Addict+Behav 2009 ; 34 (6-7): 581-6 Nephropedia Template TP {{tp|p=19345510|t=2009. Initiating acamprosate within-detoxification versus post-detoxification in the treatment of alcohol dependence |pdf=|usr=}}{{19345510}} gab.com Text Initiating acamprosate within-detoxification versus post-detoxification in the treatment of alcohol dependence JO: Addict Behav http://www.kidney.de/pget.php?&tw=1&pmid=19345510 #FOAvip OBJECTIVES: This trial compared the efficacy of acamprosate, started at the beginning of detoxification, to acamprosate started at the completion of detoxification, in the treatment of alcohol dependence. METHODS: This biphasic clinical trial consisted of a randomized, double-blind, placebo-controlled Detoxification Phase (DP), followed by a 10-week open-label Rehabilitation Phase (RP). Forty alcohol dependent patients were randomly assigned to receive either 1998 mg of acamprosate daily, or matching placebo, during the DP (5-14 days). After completing detoxification, all patients received open label acamprosate (1998 mg daily) in the RP. Outcome measures during the DP included: treatment retention, alcohol withdrawal, alcohol consumption, and oxazepam used. Outcome measures during the RP included: treatment retention and alcohol consumption. RESULTS: There were no significant outcome differences between acamprosate and placebo-treated patients during the DP. Patients given acamprosate, compared to placebo, during the DP drank more alcohol in the RP. CONCLUSIONS: Starting acamprosate at the beginning of detoxification did not improve DP outcomes. Starting acamprosate after detoxification was completed was associated with better drinking outcomes during subsequent alcohol rehabilitation treatment. Twit Text FOAVip Initiating acamprosate within-detoxification versus post-detoxification in the treatment of alcohol dependence ????Addict Behav http://www.kidney.de/pget.php?&tw=1&pmid=19345510 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=19345510 #FOAvip English Wikipedia <ref>{{Cite pmid|19345510}}</ref> Initiating acamprosate within-detoxification versus post-detoxification in the treatment of alcohol dependence #MMPMID19345510 Kampman KM; Pettinati HM; Lynch KG; Xie H; Dackis C; Oslin DW; Sparkman T; Sharkoski T; O'Brien CP Addict Behav 2009[Jun]; 34 (6-7): 581-6 PMID19345510show ga OBJECTIVES: This trial compared the efficacy of acamprosate, started at the beginning of detoxification, to acamprosate started at the completion of detoxification, in the treatment of alcohol dependence. METHODS: This biphasic clinical trial consisted of a randomized, double-blind, placebo-controlled Detoxification Phase (DP), followed by a 10-week open-label Rehabilitation Phase (RP). Forty alcohol dependent patients were randomly assigned to receive either 1998 mg of acamprosate daily, or matching placebo, during the DP (5-14 days). After completing detoxification, all patients received open label acamprosate (1998 mg daily) in the RP. Outcome measures during the DP included: treatment retention, alcohol withdrawal, alcohol consumption, and oxazepam used. Outcome measures during the RP included: treatment retention and alcohol consumption. RESULTS: There were no significant outcome differences between acamprosate and placebo-treated patients during the DP. Patients given acamprosate, compared to placebo, during the DP drank more alcohol in the RP. CONCLUSIONS: Starting acamprosate at the beginning of detoxification did not improve DP outcomes. Starting acamprosate after detoxification was completed was associated with better drinking outcomes during subsequent alcohol rehabilitation treatment. |Acamprosate[MESH] |Adult[MESH] |Alcohol Deterrents/*administration & dosage/adverse effects/therapeutic use[MESH] |Alcohol Drinking[MESH] |Alcoholism/*drug therapy/psychology/rehabilitation[MESH] |Double-Blind Method[MESH] |Drug Administration Schedule[MESH] |Drug Therapy, Combination[MESH] |Female[MESH] |Humans[MESH] |Male[MESH] |Middle Aged[MESH] |Oxazepam/therapeutic use[MESH] |Patient Compliance[MESH] |Psychiatric Status Rating Scales[MESH] |Substance Withdrawal Syndrome/*prevention & control[MESH] |Taurine/administration & dosage/adverse effects/*analogs & derivatives/therapeutic use[MESH] |Temperance[MESH]Initiating acamprosate within-detoxification versus post-detoxificatio(epmc).pdf DeepDyve Pubget Overpricing